Loading...
Loading...
Celldex Therapeutics
CLDX surged 25.34% to $6.9190 at 9:54 am. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.
Guanwei Recycling
GPRC climbed 25.15% to $2.09. Guanwei Recycling's trailing-twelve-month ROE is 33.04%.
Geron
GERN surged 24.53% to $1.32. Geron reported positive clinical results from the Phase 2 trial of imetelstat in patients with essential thrombocythemia.
Intermec
IN shares advanced 22.68% to $9.79. Honeywell International
HON announced its plans to buy Intermec for $600 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in